Picture of Percheron Therapeutics logo

PER — Percheron Therapeutics News Story

0.000.00%
au flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Brief: Antisense Therapeutics Announces Appointment Of James Garner As CEO

May 8 (Reuters) - Antisense Therapeutics Ltd  ANP.AX :
    * APPOINTMENT OF JAMES GARNER AS CHIEF EXECUTIVE OFFICER AND
MANAGING DIRECTOR
    * CHARMAINE GITTLESON WILL ASSUME ROLE OF EXECUTIVE CHAIRMAN

Source text for Eikon:  ID:nASXwRc1J 
Further company coverage:  ANP.AX 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Percheron Therapeutics

See all news